Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-26 6:43 pm Sale | 2026-06-26 | 13D | KYMERA THERAPEUTICS INC KYMR | BIOTECHNOLOGY VALUE FUND L P | 5,237,151 6.300% | -1,630,658 (-23.74%) | Filing History |
| 2026-05-15 10:06 am Purchase | 2026-03-31 | 13G | KYMERA THERAPEUTICS INC KYMR | T. Rowe Price Investment Management, Inc. | 5,460,257 6.700% | 5,460,257 (New Position) | Filing History |
| 2026-05-15 07:48 am Sale | 2026-03-31 | 13G | KYMERA THERAPEUTICS INC KYMR | Wellington Management Group LLP | 3,889,687 4.800% | -523,246 (-11.86%) | Filing History |
| 2026-05-06 11:23 am Purchase | 2026-03-31 | 13G | KYMERA THERAPEUTICS INC KYMR | FMR LLC | 11,681,450 14.300% | 2,752,876 (+30.83%) | Filing History |
| 2026-03-27 10:18 am Sale | 2026-03-13 | 13G | KYMERA THERAPEUTICS INC KYMR | VANGUARD GROUP INC | 0 0.000% | -5,231,392 (Position Closed) | Filing History |
| 2026-02-10 11:17 am Sale | 2025-12-31 | 13G | KYMERA THERAPEUTICS INC KYMR | Wellington Management Group LLP | 4,412,933 5.500% | -959,128 (-17.85%) | Filing History |
| 2026-01-08 09:09 am Purchase | 2025-12-31 | 13G | KYMERA THERAPEUTICS INC KYMR | FMR LLC | 8,928,574 11.200% | 3,048,963 (+51.86%) | Filing History |
| 2025-12-15 6:07 pm Purchase | 2025-12-11 | 13D | KYMERA THERAPEUTICS INC KYMR | BIOTECHNOLOGY VALUE FUND L P | 6,867,809 8.500% | 1,036,638 (+17.78%) | Filing History |
| 2025-12-11 5:27 pm Purchase | 2025-12-09 | 13D | KYMERA THERAPEUTICS INC KYMR | BAKER BROS. ADVISORS LP | 8,676,797 10.900% | 2,010,257 (+30.15%) | Filing History |
| 2025-11-14 12:19 pm Sale | 2025-09-30 | 13G | KYMERA THERAPEUTICS INC KYMR | T. Rowe Price Associates, Inc. | 5,097,704 7.100% | -1,547,770 (-23.29%) | Filing History |
| 2025-11-05 11:40 am Purchase | 2025-09-30 | 13G | KYMERA THERAPEUTICS INC KYMR | FMR LLC | 5,879,611 8.200% | 1,470,377 (+33.35%) | Filing History |
| 2025-08-12 10:34 am Sale | 2025-06-30 | 13G | KYMERA THERAPEUTICS INC KYMR | Wellington Management Group LLP | 5,372,061 7.700% | -624,812 (-10.42%) | Filing History |
| 2025-07-17 8:12 pm Purchase | 2025-06-30 | 13G | KYMERA THERAPEUTICS INC KYMR | BlackRock, Inc. BLK | 3,803,227 5.400% | 236,616 (+6.63%) | Filing History |
| 2025-06-30 8:26 pm Purchase | 2025-06-26 | 13D | KYMERA THERAPEUTICS INC KYMR | BAKER BROS. ADVISORS LP | 6,666,540 9.500% | 665,278 (+11.09%) | Filing History |
| 2025-05-12 10:44 am Purchase | 2025-03-31 | 13G | KYMERA THERAPEUTICS INC KYMR | Wellington Management Group LLP | 5,996,873 9.200% | 689,547 (+12.99%) | Filing History |
| 2025-05-12 10:36 am Sale | 2025-03-31 | 13G | KYMERA THERAPEUTICS INC KYMR | FMR LLC | 4,409,234 6.800% | -699,907 (-13.70%) | Filing History |
| 2025-04-30 11:12 am Purchase | 2025-03-31 | 13G | KYMERA THERAPEUTICS INC KYMR | VANGUARD GROUP INC | 5,231,392 8.050% | 1,233,828 (+30.86%) | Filing History |
| 2025-02-10 10:25 am Purchase | 2024-12-31 | 13G | KYMERA THERAPEUTICS INC KYMR | Wellington Management Group LLP | 5,307,326 8.200% | 688,967 (+14.92%) | Filing History |
| 2024-11-14 4:31 pm Sale | 2024-09-30 | 13G | KYMERA THERAPEUTICS INC KYMR | Atlas Venture Fund X, L.P. | 4,173,216 6.400% | -794,898 (-16.00%) | Filing History |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | KYMERA THERAPEUTICS INC KYMR | T. Rowe Price Associates, Inc. | 6,645,474 10.300% | 646,218 (+10.77%) | Filing History |